Investor mix
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 75% |
| Accelerator & incubator | 1 | 25% |
Develops microbiome-based therapeutics for gastrointestinal infection
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 75% |
| Accelerator & incubator | 1 | 25% |